Biocytogen Pharmaceuticals (Beijing) Co Ltd SSE:688796:

  • SHANGHAI INTELLECTUAL PROPERTY COURT DISMISSED LITIGATION CLAIMS BROUGHT BY HBM

  • REFERS TO ALLEGATION MADE BY HARBOUR ANTIBODIES B.V. ON CO'S RENNANO PLATFORM, OTHERS INFRINGED PATENT